Phathom Pharmaceuticals (PHAT) PT Raised to $25 at Guggenheim
Tweet Send to a Friend
(Updated - February 27, 2026 6:55 AM EST)
Guggenheim analyst Yatin Suneja raised the price target on Phathom Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Guggenheim analyst Yatin Suneja raised the price target on Phathom Pharmaceuticals ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
